Mobile menu
Home » Beyond Celiac Investments

Beyond Celiac Investments

What is Beyond Celiac Investments?

Beyond Celiac Investments (BCI) is an investment program designed to accelerate the development of treatments and a cure for celiac disease by leveraging the speed and scale of venture capital and capital markets. BCI launched in February of 2024 with an initial funding of $2 million.

Why was Beyond Celiac Investments Created?

There are no venture funds with a specific focus on celiac disease or autoimmune disorders. BCI allows us to invest significant resources to identify promising treatments under development as well as those that have been investigated or approved for other purposes that also might benefit celiac disease patients.

BCI is using the Development Catalyst business model, enabling drug development through nonprofit means. Using donated funds also means that all financial returns from BCI’s investments return to Beyond Celiac to be used for future investments and grants to benefit the celiac disease population and the Beyond Celiac mission to accelerate research for a cure.

How Can I Get Involved?

If you’d like to learn more, support BCI directly, or get involved, please send an email to [email protected].

Think you may have celiac disease?

Symptoms Checklist